AndhraNews.net
Home » Business News » 2012 » June » June 21, 2012

U.S. Clinical Laboratory Testing Sector Revenue to Jump to $63.8 Billion by 2016


June 21, 2012 - NEW YORK, NY

TriMarkPublications.com cites in its newly published "Clinical Laboratory Testing Volume 2: Key Players for Laboratory Testing, Business Trends and Strategies" report that U.S. clinical laboratory testing sector revenue will jump to $63.8 billion by 2016. For more information, visit: http://www.trimarkpublications.com/clinical-laboratory-testing-volume-2-key-players-for-laboratory-testing-business-trends-and-strategies.

Clinical laboratory testing can be categorized into two main modalities: clinical testing and anatomical pathology testing. Principal tests undertaken include complete blood counts, prothrombin and coagulation testing, thyroid stimulating hormone (TSH), lipid panels, blood gases and electrolytes, cardiac markers, infectious diseases, whole-blood glucose, drugs of abuse testing (DAT), urinalysis, coagulation and cardiac monitoring. In the U.S., approximately 85% of clinical diagnostic testing is currently conducted in hospital-based and commercial laboratories.

The "Clinical Laboratory Testing Volume 2: Key Players for Laboratory Testing, Business Trends and Strategies" report covers:

  • Medicare Clinical Lab Services Spending Trends
  • Hospital-based Clinical Laboratories
  • Commercial Clinical Laboratory Testing
  • Physician Office Laboratories (POLs)
  • Workplace Drugs-of-Abuse Testing
  • Clinical Toxicology
  • Vitamin D Testing
  • Diabetes (Glucose) Testing
  • Molecular Diagnostic Testing
  • Cardiac Markers
  • Blood Bank Screening
  • Genetic Testing
  • Point of Care Testing
  • Anatomic Pathology
  • Immunodiagnostics
  • Opiate Testing

The "Clinical Laboratory Testing Volume 2: Key Players for Laboratory Testing, Business Trends and Strategies" report examines companies manufacturing clinical laboratory testing equipment and supplies in the world. Companies covered include: ACM Medical, Alere, American Esoteric (Sonic), American Pathology, AmeriPath (Quest), ARUP, Athena, Aurora, Bio-Reference, BioTech MedLab, Caris, CBLPath, Centrex Clinical, Clarient, Clinical Reference, Clongen, CompuNet Clinical, EndoChoice Pathways, Enzo Biochem, Esoterix (LabCorp), Exagen, Geneva, Genomic Health, Genzyme, IBT, Integrated Regional (IRL), LabCorp, MEDTOX Scientific, Meriter Health Services, Mid America Clinical (MACL), Monogram, Myriad, National Jewish Medical and Research Center, Parkway, Pathology, Predictive, Psychemedics, Quest, RDL Reference, Satellite Services, Signal, Solstas, Sonic and Spectra.

Detailed charts with sales forecasts and marketshare data are included. For more information, visit: http://www.trimarkpublications.com/clinical-laboratory-testing-volume-2-key-players-for-laboratory-testing-business-trends-and-strategies.

About TriMarkPublications.com

TriMarkPublications.com is a global leader in the biotechnology, healthcare and life sciences market research publishing. For more information, please visit http://www.trimarkpublications.com.

Important Notice

The statements contained in this news release that are forward-looking are based on current expectations that are subject to a number of uncertainties and risks, and actual results may differ materially.

Add to Digg Bookmark with del.icio.us Add to Newsvine

Contact

TriMarkPublications.com
Media Relations
1-888-OK-TRIMARK
www.trimarkpublications.com

MarketWire

Comment on this story

Share